Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial

Background In the GLOBAL LEADERS trial, ticagrelor monotherapy beyond 1 month compared with standard antiplatelet regimens after coronary stent implantation did not improve outcomes at intention‐to‐treat analysis. Considerable differences in treatment adherence between the experimental and control g...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Felice Gragnano, Marcel Zwahlen, Pascal Vranckx, Dik Heg, Kurt Schmidlin, Christian Hamm, Philippe Gabriel Steg, Giuseppe Gargiulo, Eugene P. McFadden, Yoshinobu Onuma, Ply Chichareon, Edouard Benit, Helge Möllmann, Luc Janssens, Sergio Leonardi, Aleksander Zurakowski, Alessio Arrivi, Robert Jan Van Geuns, Kurt Huber, Ton Slagboom, Paolo Calabrò, Patrick W. Serruys, Peter Jüni, Marco Valgimigli, Stephan Windecker
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Wiley 2022-05-01
Reeks:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Onderwerpen:
DAPT
intention‐to‐treat
P2Y12 inhibitor monotherapy
per‐protocol
ticagrelor
Online toegang:https://www.ahajournals.org/doi/10.1161/JAHA.121.024291
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items